共 50 条
- [4] Healthcare Resource Utilization and Costs in Patients with Myelodysplastic Syndromes Treated with Hypomethylating Agents: A SEER-Medicare Analysis [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S314 - S314
- [8] Myelodysplastic syndromes and the risk of cardiovascular disease in older adults: A SEER-medicare analysis [J]. Leukemia, 2020, 34 : 1689 - 1693